Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2021

Nov 23, 2021

34129_dirs_2021-11-23_9a108762-4a83-46bb-aec4-57321dd02139.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2021-11-19

Reporting Person: BIOTECH TARGET N V (10% Owner)
Reporting Person: BB BIOTECH AG (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-19 Common Stock P 200000 $18.5016 Acquired 7275564 Direct